FIG. 7.
mbIL-12 does not provide protection against subsequent challenge. PCI in mice (n = 5) treated with PBS−/−, FFLvMMC, or FFL/IL-12vMMC at 1 × 106 and challenged with 1 × 104 MOSE-LFFLv at week 5. MMC, mitomycin-C; PCI, peritoneal cancer index.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.